Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nam, Dong Hyuk | - |
dc.contributor.author | Lee, Kwang Seob | - |
dc.contributor.author | Kim, Sang Hoon | - |
dc.contributor.author | Kim, Sung Min | - |
dc.contributor.author | Jung, Seo Yun | - |
dc.contributor.author | Chung, Sung Hyun | - |
dc.contributor.author | Kim, Hyoung Ja | - |
dc.contributor.author | Kim, Nam Doo | - |
dc.contributor.author | Jin, Changbae | - |
dc.contributor.author | Lee, Yong Sup | - |
dc.date.accessioned | 2024-01-21T00:01:48Z | - |
dc.date.available | 2024-01-21T00:01:48Z | - |
dc.date.created | 2021-09-03 | - |
dc.date.issued | 2008-01-01 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/133826 | - |
dc.description.abstract | Calpains are involved in a variety of calcium-regulated cellular processes, such as signal transduction, cell proliferation, differentiation, and apoptosis. Excessive calpain activation contributes to serious cellular damage and has been reported in many pathological conditions. 4-Quinolinone 2-carboxamide derivatives were prepared and evaluated for mu-calpain inhibitory activities. Of the compounds synthesized, 3a and 3k, which possess a primary amide and 4-methoxyphenethyl amide at P-1' region, were found to most potently inhibit mu-calpain with IC50 values of 0.71 +/- 0.07 and 0.73 +/- 0.23 mu M, respectively. On the other hand, the incorporation of pyridine-containing amides decreased inhibitory activity. (C) 2007 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmcl.2007.10.097 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.18, no.1, pp.205 - 209 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 18 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 205 | - |
dc.citation.endPage | 209 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000253720300034 | - |
dc.identifier.scopusid | 2-s2.0-37649016170 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | calpain | - |
dc.subject.keywordAuthor | inhibitor | - |
dc.subject.keywordAuthor | stroke | - |
dc.subject.keywordAuthor | 4-quinolinone | - |
dc.subject.keywordAuthor | chromone | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.